Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Code:
NCT03949855
Conditions
Membranous Nephropathy
Nephrotic Syndrome
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Belimumab
Placebo for Belimumab
Rituximab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-19. This information was provided to ClinicalTrials.gov by National Institute of Allergy and Infectious Diseases (NIAID) on 2025-09-26.